PAPER Corbett A, Williams G, Ballard C
SEARCH RESULTS
330059 RESULTS
PAPER Dean DC 3rd, Jerskey BA, Chen K, Protas H, Thiyyagura P, Roontiva A, O'Muircheartaigh J, Dirks H, Waskiewicz N, Lehman K, Siniard AL, Turk MN, Hua X, Madsen SK, Thompson PM, Fleisher AS, Huentelman MJ, Deoni SC, Reiman EM
Brain differences in infants at differential genetic risk for late-onset Alzheimer disease: a cross-sectional imaging study.
JAMA Neurol. 2014 Jan;71(1):11-22. PubMed: 24276092PAPER Ng A, Chew I, Narasimhalu K, Kandiah N
Effectiveness of Montreal Cognitive Assessment for the diagnosis of mild cognitive impairment and mild Alzheimer's disease in Singapore.
Singapore Med J. 2013 Nov;54(11):616-9. PubMed: 24276096PAPER Coleman N, Ates-Alagoz Z, Gaye B, Farbaniec M, Sun S, Adejare A
Toxicity Studies on Novel N-Substituted Bicyclo-Heptan-2-Amines at NMDA Receptors.
Pharmaceuticals (Basel). 2013 Apr 12;6(4):536-45. PubMed: 24276123PAPER Weinstein G, Beiser AS, Choi SH, Preis SR, Chen TC, Vorgas D, Au R, Pikula A, Wolf PA, DeStefano AL, Vasan RS, Seshadri S
Serum brain-derived neurotrophic factor and the risk for dementia: the Framingham Heart Study.
JAMA Neurol. 2014 Jan;71(1):55-61. PubMed: 24276217PAPER Leong SL, Young TR, Barnham KJ, Wedd AG, Hinds MG, Xiao Z, Cappai R
Quantification of copper binding to amyloid precursor protein domain 2 and its Caenorhabditis elegans ortholog. Implications for biological function.
Metallomics. 2014 Jan;6(1):105-16. PubMed: 24276282PAPER Prakash A, Kumar A
Role of nuclear receptor on regulation of BDNF and neuroinflammation in hippocampus of β-amyloid animal model of Alzheimer's disease.
Neurotox Res. 2014 May;25(4):335-47. Epub 2013 Nov 26 PubMed: 24277156PAPER Lastres-Becker I, Innamorato NG, Jaworski T, Rábano A, Kügler S, Van Leuven F, Cuadrado A
Fractalkine activates NRF2/NFE2L2 and heme oxygenase 1 to restrain tauopathy-induced microgliosis.
Brain. 2014 Jan;137(Pt 1):78-91. Epub 2013 Nov 25 PubMed: 24277722PAPER Hsieh IC, Kuan TS, Hsieh PC, Chen SM, Yen WJ, Chang WC, Lin IL, Lin YC
Detection of early cognitive impairment using AD8 in a young patient with stroke with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy syndrome: a case report.
Am J Alzheimers Dis Other Demen. 2014 Mar;29(2):133-7. Epub 2013 Nov 24 PubMed: 24277909PAPER Benhabib H, Lanctôt KL, Eryavec GM, Li A, Herrmann N
Responsiveness of the QUALID to Improved Neuropsychiatric Symptoms in Patients with Alzheimer's Disease.
Can Geriatr J. 2013;16(4):180-5. Epub 2013 Dec 3 PubMed: 24278094PAPER Schmidt C, Becker H, Zerr I
Cerebrospinal fluid apolipoprotein e concentration and severity of cognitive impairment in patients with newly diagnosed Alzheimer's disease.
Am J Alzheimers Dis Other Demen. 2014 Feb;29(1):54-60. Epub 2013 Nov 24 PubMed: 24277910PAPER Ramos-Rodriguez JJ, Molina-Gil S, Rey-Brea R, Berrocoso E, Garcia-Alloza M
Specific serotonergic denervation affects tau pathology and cognition without altering senile plaques deposition in APP/PS1 mice.
PLoS One. 2013;8(11):e79947. Epub 2013 Nov 21 PubMed: 24278223PAPER Natunen T, Martiskainen H, Sarajärvi T, Helisalmi S, Pursiheimo JP, Viswanathan J, Laitinen M, Mäkinen P, Kauppinen T, Rauramaa T, Leinonen V, Alafuzoff I, Haapasalo A, Soininen H, Hiltunen M
Effects of NR1H3 genetic variation on the expression of liver X receptor α and the progression of Alzheimer's disease.
PLoS One. 2013;8(11):e80700. Epub 2013 Nov 20 PubMed: 24278306PAPER Guo Q, Li H, Cole AL, Hur JY, Li Y, Zheng H
Modeling Alzheimer's Disease in mouse without mutant protein overexpression: cooperative and independent effects of Aβ and tau.
PLoS One. 2013;8(11):e80706. Epub 2013 Nov 20 PubMed: 24278307PAPER Kopeikina KJ, Wegmann S, Pitstick R, Carlson GA, Bacskai BJ, Betensky RA, Hyman BT, Spires-Jones TL
Tau causes synapse loss without disrupting calcium homeostasis in the rTg4510 model of tauopathy.
PLoS One. 2013;8(11):e80834. Epub 2013 Nov 20 PubMed: 24278327Current Filters
No filters selected